Prosecution Insights
Last updated: October 04, 2026

Stallion Catheter Inc.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Stallion Catheter Inc. has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is being reviewed by 1 distinct examiner, GRASMEDER, SARAH DYMPNA, who is the busiest examiner for the portfolio. The prosecution is currently limited to 1 distinct art unit, showing a concentrated technical focus.

The presence of only 1 pending office action means that the company's immediate patent strategy is focused on a single point of contact. GRASMEDER, SARAH DYMPNA is responsible for the 1 busiest examiner pending action, so their specific history and preferences are the most critical factors for the practitioner to consider. There is no diversity in the 1 distinct art unit, which suggests the current legal work is technically homogeneous.

For the practitioner, this concentration simplifies the management of the portfolio but increases the impact of this single examiner's decisions. Since there is only 1 distinct examiner involved, there are no opportunities to leverage different examiner behaviors to inform strategy. The resolution of the 1 pending office action will determine the immediate success of the company's efforts in the Medical Devices & Mechanical Engineering sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GRASMEDER, SARAH DYMPNA 1 72.2% +32.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17998008 GUIDE CATHETER GRASMEDER, SARAH DYMPNA 70d

Top Art Units

Art UnitApps
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17998008 GUIDE CATHETER GRASMEDER, SARAH DYMPNA 3783 §103 Final Rejection 70d Pending Nov 04, 2022

Managing Stallion Catheter Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month